» Articles » PMID: 29566716

Overexpression of Zinc-α2-glycoprotein Suppressed Seizures and Seizure-related Neuroflammation in Pentylenetetrazol-kindled Rats

Overview
Publisher Biomed Central
Date 2018 Mar 24
PMID 29566716
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Zinc-α2-glycoprotein (ZAG) is a 42-kDa protein reported as an anti-inflammatory adipocytokine. Evidences from clinical and experimental studies revealed that brain inflammation plays important roles in epileptogenesis and seizure. Interestingly, closely relationship between ZAG and many important inflammatory mediators has been proven. Our previous study identified ZAG in neurons and found that ZAG is decreased in epilepsy and interacts with TGFβ and ERK. This study aimed to investigate the role of ZAG in seizure and explore its effect on seizure-related neuroinflammation.

Methods: We overexpressed AZGP1 in the hippocampus of rats via adeno-associated virus vector injection and observed their seizure behavior and EEG after pentylenetetrazol (PTZ) kindling. The level of typical inflammation mediators including TNFα, IL-6, TGFβ, ERK, and ERK phosphorylation were determined.

Results: The overexpression of AZGP1 reduced the seizure severity, prolonged the latency of kindling, and alleviated epileptiform discharges in EEG changes induced by PTZ. Overexpression of AZGP1 also suppressed the expression of TNFα, IL-6, TGFβ, and ERK phosphorylaton in PTZ-kindled rats.

Conclusions: ZAG may inhibit TGFβ-mediated ERK phosphorylation and inhibit neuroinflammation mediated by TNFα and IL-6, suggesting ZAG may suppress seizure via inhibiting neuroinflammation. ZAG may be a potential and novel therapeutic target for epilepsy.

Citing Articles

Anticonvulsant effect of glycitin in pentylenetetrazol induced male Wistar rat model by targeting oxidative stress and Nrf2/HO-1 signaling.

Hakimi Naeini S, Rajabi-Maham H, Azizi V, Hosseini A Front Pharmacol. 2024; 15:1392325.

PMID: 39246658 PMC: 11377222. DOI: 10.3389/fphar.2024.1392325.


Glutathione peroxidase 3 is a potential biomarker for konzo.

Bramble M, Fourcassie V, Vashist N, Roux-Dalvai F, Zhou Y, Bumoko G Nat Commun. 2024; 15(1):7811.

PMID: 39242582 PMC: 11379914. DOI: 10.1038/s41467-024-52136-5.


Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome.

Qian Y, Tong Y, Zeng Y, Huang J, Liu K, Xie Y J Transl Med. 2024; 22(1):364.

PMID: 38632610 PMC: 11022415. DOI: 10.1186/s12967-024-05167-x.


Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment.

Hanamura T, Yokoyama K, Kitano S, Kagamu H, Yamashita M, Terao M Cancer Immunol Immunother. 2024; 73(3):42.

PMID: 38349455 PMC: 10864576. DOI: 10.1007/s00262-024-03629-1.


Zinc-a2-Glycoprotein Acts as a Component of PNN to Protect Hippocampal Neurons from Apoptosis.

Chang K, Lin L, Cui T, Zhao H, Li J, Liu C Mol Neurobiol. 2023; 61(6):3607-3618.

PMID: 38001359 DOI: 10.1007/s12035-023-03771-4.


References
1.
Yu C, Gui W, He H, Wang X, Zuo J, Huang L . Neuronal and astroglial TGFβ-Smad3 signaling pathways differentially regulate dendrite growth and synaptogenesis. Neuromolecular Med. 2014; 16(2):457-72. DOI: 10.1007/s12017-014-8293-y. View

2.
Taha A, Burnham W, Auvin S . Polyunsaturated fatty acids and epilepsy. Epilepsia. 2010; 51(8):1348-58. DOI: 10.1111/j.1528-1167.2010.02654.x. View

3.
Yang T, Zhou D, Stefan H . Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression?. J Neurol Sci. 2010; 296(1-2):1-6. DOI: 10.1016/j.jns.2010.06.002. View

4.
Bartfai T, Schultzberg M . Cytokines in neuronal cell types. Neurochem Int. 1993; 22(5):435-44. DOI: 10.1016/0197-0186(93)90038-7. View

5.
Cacheaux L, Ivens S, David Y, Lakhter A, Bar-Klein G, Shapira M . Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci. 2009; 29(28):8927-35. PMC: 2875073. DOI: 10.1523/JNEUROSCI.0430-09.2009. View